Skip to main content
Premium Trial:

Request an Annual Quote

Small Company, Big Drug

Will biotech “castoffs” develop the next blockbuster drugs?, asks a recent Wall Street Journal article ($). The article profiles Speedel Holding AG, and its founder Alice Huxley, who successfully created and developed drug aliskiren as a potential blockbuster—in the privacy of her own home.  Big pharma are casting off slow-to-move projects, and small startups, such as Huxley’s own company, are finding opportunities in the rejects.


The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.